That’s just how FA works. You pay for a players decline years but it’s the only way to get a player of that quality without either developing them or paying through the nose. Just a balance of having a couple of those players along with young ones who are more controllable cost wise. Hopefully Springer and Ryu keep going for longer. Sometimes you get a unicorn who keeps playing at high level through the thirties but that’s rarer in the post steroid era. I’d be ecstatic if he stays at 4-5 that’s a top 20 player. My concern is if he drops in the 2-3.5 range.
|